ADMA Biologics
ADMA
ADMA
184 hedge funds and large institutions have $782M invested in ADMA Biologics in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 71 increasing their positions, 58 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
2% less funds holding
Funds holding: 188 → 184 (-4)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
184
Holding in Top 10
4
Calls
$619K
Puts
$18K
Top Buyers
| 1 | +$13.3M | |
| 2 | +$10.5M | |
| 3 | +$10.2M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$8.68M |
| 5 |
BlackRock
New York
|
+$5.69M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$7.36M | |
| 3 | -$4.92M | |
| 4 |
D.E. Shaw & Co
New York
|
-$4.78M |
| 5 |
FAM
Fred Alger Management
New York
|
-$4.27M |